SPRY Operating Cash Flow (Statement)
Ars Pharmaceuticals Inc · Operating Cash Flow (Statement)
SPRY Operating Cash Flow (Statement)
Latest reported-$196.41Mperiod ending
SPRY TTM Cash from Operations (-$39.41M → -$196.41M)
TTM operating cash flow (statement)
High-resolution chart · PNG
SPRY operating cash flow (statement) history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -196,405,000 | |
| -175,070,000 | |
| -170,866,000 | |
| -85,377,000 | |
| -52,797,000 | |
| -20,484,000 | |
| 13,548,000 | |
| -45,861,000 | |
| -44,157,000 | |
| -53,547,000 | |
| -59,266,000 | |
| -62,358,000 | |
| -55,277,000 | |
| -45,582,000 | |
| -40,078,000 | |
| -40,886,000 | |
| -54,323,000 | |
| -61,484,000 | |
| -66,760,000 | |
| -50,898,000 | |
| -39,407,000 |